NYMC Faculty Publications

Arachidonic Acid Monooxygenase: Genetic and Biochemical Approaches to Physiological/Pathophysiological Relevance

Author Type(s)

Faculty

DOI

10.1016/j.prostaglandins.2015.05.004

Journal Title

Prostaglandins & Other Lipid Mediators

First Page

40

Last Page

49

Document Type

Article

Publication Date

7-1-2015

Department

Pharmacology

Keywords

Animals, Blood Pressure, Cytochrome P-450 CYP2J2, Cytochrome P-450 Enzyme System, Epithelial Sodium Channels, Humans, Hypertension, Sodium

Disciplines

Medicine and Health Sciences

Abstract

Studies with rat genetic models of hypertension pointed to roles for the CYP2C and CYP4A arachidonic acid epoxygenases and ω-hydroxylases in tubular transport, hemodynamics, and blood pressure control. Further progress in defining their physiological functions and significance to human hypertension requires conclusive identifications of the relevant genes and proteins. Here we discuss unequivocal evidence of roles for the murine Cyp4a14, Cyp4a10, and Cyp2c44 genes in the pathophysiology of hypertension by showing that: (a) Cyp4a14(-/-) mice develop sexually dimorphic hypertension associated with renal vasoconstriction, and up-regulated expression of Cyp4a12a and pro-hypertensive 20-hydroxyeicosatetraenoic acid (20-HETE) levels, and b) Cyp4a10(-/-) and Cyp2c44(-/-) mice develop salt sensitive hypertension linked to downregulation or lack of the Cyp2c44 epoxygenase, reductions in anti-hypertensive epoxyeicosatrienoic acids (EETs), and increases in distal sodium reabsorption. Based on these studies, the human CYP4A11 and CYPs 2C8 and 2C9 genes and their products are identified as potential candidates for studies of the molecular basis of human hypertension.

Link to Full Text

Share

COinS